Lonza goes with the Flow Chemistry with latest API platform
Lonza has launched an API-making platform that uses chemical microreaction technology for continuous processing.
Archives for October 6, 2014
MedImmune gets patent for MDCK cell line to speed flu vaccine production
AstraZeneca’s biologics wing MedIummune has been granted a US patent for an optimised cell line used to make infleunza vaccine.
Green chemistry makes 'cents' for cost-focused API firms says expert
Making drugs generates a huge amount of waste but industry is showing signs of cleaning up its act according to Paul Anastas, the Yale scientist who coined the phrase "green chemistry."
Baxter Transitions Biopharma R&D to a New Hub in Cambridge
Baxter International plans to set up a new global R&D center in Cambridge, Mass, for Baxalta, its biopharmaceuticals spinoff, which is expected be formally incorporated next year and headquartered in northern Illinois.
INC Research preps to jump on the IPO bandwagon with SEC filing
Following pushes to go public by top peers, CRO INC Research has filed an S-1 with the SEC in preparation for an IPO (initial public offering) on the NASDAQ.
Dispatches from EDQM conference
EDQM set to fight fakes and forge closer ties with EMA
Counterfeit drugs and collaboration will be key topics for the EDQM say delegates at the organisation's 50th anniversary conference on Monday.